Pyroptosis: a potential target and research progress of exercise in ameliorating Alzheimer's disease pathology.
- 1School of Physical Education, Qufu Normal University, Qufu, Shandong, China.
Abstract
Alzheimer's disease (AD), a debilitating neurodegenerative disorder that severely threatens elderly health, is clinically manifested as cognitive decline and driven by core pathological hallmarks including amyloid-beta (Aβ) deposition, tau hyperphosphorylation, and chronic neuroinflammation. Recent studies have indicated that its pathophysiological process is closely associated with pyroptosis, and excessive activation of pyroptosis drives a vicious cycle of amplified inflammation and neuronal injury. Although accumulating evidence suggests that exercise serves as an effective non-pharmacological intervention to suppress pyroptosis and alleviate AD, the intrinsic interactive mechanisms among exercise, pyroptosis and the pathological progression of AD remain incompletely elucidated. Therefore, this review systematically summarizes the functional mechanisms of pyroptosis in the pathological progression of AD and discusses the potential neuroprotective effects of exercise intervention. It further focuses on analyzing the specific mechanisms by which exercise inhibits pyroptosis via regulating the NLRP3 inflammasome pathway, aiming to identify novel targets for the prevention and treatment of AD and provide a theoretical basis for formulating scientific exercise intervention strategies.
Related
- HMGB1 in Amyloid-Beta Pathology: Mechanistic Insights and Therapeutic Implications for Alzheimer’s Disease
- Two functionally distinct amyloid-β intermediates link aggregation pathways to pathology in Alzheimer's disease
- Decoding pyroptosis at single-cell resolution: heterogeneity, microenvironment remodeling and potential translational insights
- Alzheimer’s disease research must connect vascular molecular phenotypes with physiology
- In situ CAR-M engineered by liposomal mRNA nanomedicine remodels fibrotic microenvironment for ameliorating liver fibrosis
BibTeX
@article{jie2026pyroptosis,
title = {{Pyroptosis: a potential target and research progress of exercise in ameliorating Alzheimer's disease pathology.}},
author = {Shao Jie and Zhu Lei},
journal = {Frontiers in aging neuroscience},
year = {2026},
month = oct,
doi = {10.3389/fnagi.2026.1983962},
url = {https://europepmc.org/article/MED/42909413},
note = {CC BY},
}
RIS
TY - JOUR
TI - Pyroptosis: a potential target and research progress of exercise in ameliorating Alzheimer's disease pathology.
AU - Shao Jie
AU - Zhu Lei
PY - 2026
DA - 2026/10/07
JO - Frontiers in aging neuroscience
DO - 10.3389/fnagi.2026.1983962
UR - https://europepmc.org/article/MED/42909413
AB - Alzheimer's disease (AD), a debilitating neurodegenerative disorder that severely threatens elderly health, is clinically manifested as cognitive decline and driven by core pathological hallmarks including amyloid-beta (Aβ) deposition, tau hyperphosphorylation, and chronic neuroinflammation. Recent studies have indicated that its pathophysiological process is closely associated with pyroptosis, and excessive activation of pyroptosis drives a vicious cycle of amplified inflammation and neuronal injury. Although accumulating evidence suggests that exercise serves as an effective non-pharmacological intervention to suppress pyroptosis and alleviate AD, the intrinsic interactive mechanisms among exercise, pyroptosis and the pathological progression of AD remain incompletely elucidated. Therefore, this review systematically summarizes the functional mechanisms of pyroptosis in the pathological progression of AD and discusses the potential neuroprotective effects of exercise intervention. It further focuses on analyzing the specific mechanisms by which exercise inhibits pyroptosis via regulating the NLRP3 inflammasome pathway, aiming to identify novel targets for the prevention and treatment of AD and provide a theoretical basis for formulating scientific exercise intervention strategies.
SN - 1663-4365
ER -